Report Detail
Neurovascular Intervention Devices Global Market - Forecast to 2024
- RnM2097187 |
- 12 March, 2020 |
- Global |
- 392 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Neurovascular Intervention devices are used treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula, etc. According to IQ4I analysis, the Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR to reach $4,473.2 million by 2024. The increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, acquisitions and favourable reimbursements are increasing the use of artificial embolization devices, stents, thromobectomy devices and support devices which include microcatheters, embolic protection system and others as an efficient way for treating the neurovascular diseases.
Neurovascular Intervention devices global market is segmented on the basis of products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. The artificial embolization devices segment accounted the largest share in 2017 and is projected to grow at mid single digit CAGR from 2017 to 2024 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation. The artificial embolization devices are sub-segment into coils, liquid embolics, flow diverter and flow disruptor. The coil segment accounted the largest share in 2017 due to development of softest coils and more number of companies producing bare metal coils over coated coils due to its advantages. The liquid embolics segment is fastest growing segment and is projected to grow at a strong CAGR of 8.7% from 2017 to 2024 due to its advantages like presence of effective embolic materials which penetrates small vessels, cohesiveness and non-adherence when compared to glues. The coils are further classified into bare metal coils and coated coils. The bare metal coil segment accounted for the largest share in 2017 and fastest growing segment and is projected to grow at a CAGR of 6.4% from 2017 to 2024 due to increased compatibility, efficacy and cost efficient. The Stents are sub-segmented into intracranial stents and carotid stents. The carotid stents segment accounted the largest share of 74.2% and fastest growing segment in 2017 due to development of self expanding stents. The intracranial stents are sub-segmented into stenosis stent, aneurysm coil stent, neck reconstruction stent and stent graft. The aneurysm coil stents segment accounted the largest share in 2017 and fastest growing segment during forecasting period due to increase intracranial aneurysm procedures. The thrombectomy devices are sub-segmented into stent retrievers and aspiration devices. The stent retriever segment accounted the largest share of 76.3% and fastest growing segment from 2017 to 2024 due to product approvals and expansion in indication of treatment from 6 hrs to 24 hrs. The Support devices are sub-segmented into microcatheters, embolic protection system and others. The microcatheter segment accounted the largest share in 2017.
The applications are segmented into intracranial aneurysm, ischemic stroke, arteriovenous malformation and carotid stenosis & others. Among application, intracranial aneurysm segment accounted for the largest share in 2017 due to the increase in incidence and prevalence of intracranial aneurysm and increase in aging population. The Ischemic stroke segment is fastest growing segment during forecasting period due to increase in product regulatory approvals of thrombectomy devices, increase in ischemic stroke patients and procedures, technological advancement in stent retriever and aspiration devices.
Geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounts for the highest market share followed by Europe. Favourable reimbursement coverage and increase in incidence and prevalence of neurovascular diseases are the driving factors of Neurovascular Intervention devices market. However, Asian countries especially India and China are the fastest growing nations at strong CAGR of 11.4% from 2017 to 2024 with its growing demand for neurovascular intervention device due to increase in aging population and decreasing the cost of neurovascular products.
The Neurovascular Intervention devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Neurovascular Intervention device are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Terumo Corporation (Japan), Balt Extrusion (Blockade Medical, LLC) (France), Penumbra, Inc. (U.S.), Johnson & Johnson (U.S.), Acandis GmbH (Germany), Microport Scientific Corporation (China), Phenox GmbH (Germany), Penumbra Inc (U.S.), Abbott Laboratories (U.S.), InspireMD (Israel), Boston Scientific Corporation (U.S.) and Cardinal Health (Cordis Corporation) (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others
• Europe
o Germany
o U.K.
o France
o Others
• Asia-Pacific
o Japan
o China
o India
o Others
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East & Others
1 EXECUTIVE SUMMARY 26
2 INTRODUCTION 32
- 2.1 KEY TAKEAWAYS 32
- 2.2 REPORT SCOPE 33
- 2.3 REPORT DESCRIPTION 33
- 2.4 MARKETS COVERED 35
- 2.5 STAKEHOLDERS 37
- 2.6 RESEARCH METHODOLOGY 37
- 2.6.1 MARKET SIZE ESTIMATION 38
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 41
- 2.6.3 SECONDARY SOURCES 42
- 2.6.4 PRIMARY SOURCES 42
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 43
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 44
- 2.6.7 ASSUMPTIONS 44
3 MARKET ANALYSIS 46
- 3.1 INTRODUCTION 46
- 3.2 MARKET SEGMENTATION 47
- 3.3 FACTORS INFLUENCING MARKET 49
- 3.3.1 DRIVERS AND OPPORTUNITIES 50
- 3.3.1.1 Increase in incidence and prevalence of neurovascular diseases 50
- 3.3.1.2 Increase in ageing population 50
- 3.3.1.3 Technological advancements in minimally invasive products 51
- 3.3.1.4 Favorable reimbursement policies 52
- 3.3.1.5 Acquisitions 53
- 3.3.2 RESTRAINTS AND THREATS 53
- 3.3.2.1 Adverse events and complications with the implantations of neurovascular intervention devices 53
- 3.3.2.2 Lack of skilled and trained professionals 54
- 3.3.2.3 Product recalls 54
- 3.3.2.4 Stringent regulatory polices 55
- 3.3.2.5 Availability of alternative products 56
- 3.3.1 DRIVERS AND OPPORTUNITIES 50
- 3.4 REGULATORY AFFAIRS 56
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 57
- 3.4.1.1 ISO 9001: 2015 Quality Management system 57
- 3.4.1.2 ISO 13485 Medical devices 57
- 3.4.1.3 ISO 10993 Biological evaluation of medical devices 58
- 3.4.2 U.S. 58
- 3.4.3 CANADA 60
- 3.4.4 EUROPE 60
- 3.4.5 JAPAN 61
- 3.4.6 CHINA 62
- 3.4.7 INDIA 64
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 57
- 3.5 REIMBURSEMENT SCENARIO 65
- 3.5.1 REIMBURSEMENT TABLE 66
- 3.6 CLINICAL TRIALS 73
- 3.7 PATENT TRENDS 75
- 3.8 TECHNOLOGICAL ADVANCEMENTS 77
- 3.8.1 INTRODUCTION 77
- 3.8.2 INTEGRATED BALLOON SYSTEM 77
- 3.8.3 SOFT COIL TECHNOLOGY 78
- 3.8.4 ADUJSTABLE CLOT RETREIVER 78
- 3.8.5 ADVANCEMENTS IN FLOW DIVERTER 78
- 3.9 PRODUCT APPROVALS 79
- 3.10 PORTER’S FIVE FORCE ANALYSIS 84
- 3.10.1 THREAT OF NEW ENTRANTS 85
- 3.10.2 THREAT OF SUBSTITUTES 85
- 3.10.3 RIVALRY AMONG EXISTING COMPETITORS 86
- 3.10.4 BARGAINING POWER OF SUPPLIERS 86
- 3.10.5 BARGAINING POWER OF BUYERS 87
- 3.11 SUPPLY CHAIN ANALYSIS 88
- 3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 91
- 3.12.1 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET SHARE ANALYSIS 91
- 3.12.2 COILS GLOBAL MARKET SHARE ANALYSIS 94
- 3.12.3 FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS 96
- 3.12.4 INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS 98
- 3.12.5 CAROTID STENT GLOBAL MARKET SHARE ANALYSIS 100
- 3.12.6 STENT RETRIEVER GLOBAL MARKET SHARE ANALYSIS 102
- 3.13 NEUROVASCULAR INTERVENTION DEVICES NUMBER OF UNITS BY
REGION 104
- 3.13.1 COILS NUMBER OF UNITS BY REGION 104
- 3.13.2 LIQUID EMBOLICS NUMBER OF UNITS BY REGION 105
- 3.13.3 STENT RETRIEVER NUMBER OF UNITS BY REGION 107
- 3.13.4 CAROTID STENT NUMBER OF UNITS BY REGION 109
TABLE BY CLASSIFICATION, PRODUCTS AND APPLICATIONS 111
- 3.15 MARKET PENETRATION OF NEUROVASCULAR INTERVENTION
DEVICE MARKET 120
4 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET,
BY PRODUCT 122
- 4.1 INTRODUCTION 122
- 4.2 ARTIFICIAL EMBOLIZATION DEVICES 124
- 4.2.1 COILS 129
- 4.2.1.1 Bare metal coils 134
- 4.2.1.2 Coated coils 136
- 4.2.2 LIQUID EMBOLICS 138
- 4.2.3 FLOW DIVERTERS 140
- 4.2.4 FLOW DISRUPTOR 142
- 4.2.1 COILS 129
- 4.3 STENTS 144
- 4.3.1 INTRACRANIAL STENTS 149
- 4.3.1.1 Stenosis stents 153
- 4.3.1.2 Aneurysm coil stents 155
- 4.3.1.3 Neck reconstruction stents 157
- 4.3.1.4 Stent graft 159
- 4.3.2 CAROTID STENTS 161
- 4.3.1 INTRACRANIAL STENTS 149
- 4.4 THROMBECTOMY DEVICES 163
- 4.4.1 STENT RETRIEVERS 167
- 4.4.2 ASPIRATION DEVICES 169
- 4.5 SUPPORT DEVICES 171
- 4.5.1 MICROCATHETERS 175
- 4.5.2 EMBOLIC PROTECTION SYSTEM 178
- 4.5.3 OTHERS 180
5 NEUROVASCULAR INTERVENTION DEVICES GLOBAL MARKET, BY APPLICATION 184
- 5.1 INTRODUCTION 184
- 5.2 INTRACRANIAL ANEURYSM 187
- 5.3 ISCHEMIC STROKE 190
- 5.4 ARTERIOVENOUS MALFORMATION 193
- 5.5 CAROTID STENOSIS AND OTHERS 195
6 REGIONAL ANALYSIS 198
- 6.1 INTRODUCTION 198
- 6.2 NORTH AMERICA 201
- 6.2.1 U.S. 215
- 6.2.2 OTHERS 217
- 6.3 EUROPE 219
- 6.3.1 GERMANY 233
- 6.3.2 U.K. 235
- 6.3.3 FRANCE 237
- 6.3.4 OTHERS 239
- 6.4 APAC 241
- 6.4.1 JAPAN 255
- 6.4.2 CHINA 257
- 6.4.3 INDIA 259
- 6.4.4 OTHERS 261
- 6.5 ROW 263
- 6.5.1 BRAZIL 276
- 6.5.2 REST OF LATIN AMERICA 278
- 6.5.3 MIDDLE EAST AND OTHERS 280
7 COMPETITIVE LANDSCAPE 282
- 7.1 INTRODUCTION 282
- 7.2 AGREEMENT 283
- 7.3 APPROVALS 286
- 7.4 ACQUISITIONS 288
- 7.5 NEW PRODUCT LAUNCH 291
- 7.6 OTHER DEVELOPMENTS 292
8 MAJOR COMPANIES 298
- 8.1 ABBOTT LABORATORIES 298
- 8.1.1 OVERVIEW 298
- 8.1.2 FINANCIALS 299
- 8.1.3 PRODUCT PORTFOLIO 301
- 8.1.4 KEY DEVELOPMENTS 301
- 8.1.5 BUSINESS STRATEGY 302
- 8.1.6 SWOT ANALYSIS 303
- 8.2 ACANDIS GMBH 304
- 8.2.1 OVERVIEW 304
- 8.2.2 FINANCIALS 304
- 8.2.3 PRODUCT PORTFOLIO 305
- 8.2.4 KEY DEVELOPMENTS 305
- 8.2.5 BUSINESS STRATEGY 306
- 8.2.6 SWOT ANALYSIS 307
- 8.3 BALT EXTRUSION 308
- 8.3.1 OVERVIEW 308
- 8.3.2 FINANCIALS 308
- 8.3.3 PRODUCT PORTFOLIO 309
- 8.3.4 KEY DEVELOPMENTS 310
- 8.3.5 BUSINESS STRATEGY 310
- 8.3.6 SWOT ANALYSIS 311
- 8.4 BOSTON SCIENTIFIC CORPORATION 312
- 8.4.1 OVERVIEW 312
- 8.4.2 FINANCIALS 313
- 8.4.3 PRODUCT PORTFOLIO 315
- 8.4.4 KEY DEVELOPMENTS 316
- 8.4.5 BUSINESS STRATEGY 316
- 8.4.6 SWOT ANALYSIS 317
- 8.5 CARDINAL HEALTH INC. (CORDIS CORPORATION) 318
- 8.5.1 OVERVIEW 318
- 8.5.2 FINANCIALS 319
- 8.5.3 PRODUCT PORTFOLIO 321
- 8.5.4 KEY DEVELOPMENTS 322
- 8.5.5 BUSINESS STRATEGY 322
- 8.5.6 SWOT ANALYSIS 323
- 8.6 INSPIREMD, INC. 324
- 8.6.1 OVERVIEW 324
- 8.6.2 FINANCIALS 325
- 8.6.3 PRODUCT PORTFOLIO 328
- 8.6.4 KEY DEVELOPMENTS 328
- 8.6.5 BUSINESS STRATEGY 331
- 8.6.6 SWOT ANALYSIS 332
- 8.7 JOHNSON & JOHNSON 333
- 8.7.1 OVERVIEW 333
- 8.7.2 FINANCIALS 334
- 8.7.3 PRODUCT PORTFOLIO 339
- 8.7.4 KEY DEVELOPMENTS 340
- 8.7.5 BUSINESS STRATEGY 342
- 8.7.6 SWOT ANALYSIS 343
- 8.8 MEDTRONIC, PLC 344
- 8.8.1 OVERVIEW 344
- 8.8.2 FINANCIALS 345
- 8.8.3 PRODUCT PORTFOLIO 349
- 8.8.4 KEY DEVELOPMENTS 351
- 8.8.5 BUSINESS STRATEGY 352
- 8.8.6 SWOT ANALYSIS 353
- 8.9 MICROPORT SCIENTIFIC CORPORATION 354
- 8.9.1 OVERVIEW 354
- 8.9.2 FINANCIALS 355
- 8.9.3 PRODUCT PORTFOLIO 358
- 8.9.4 KEY DEVELOPMENTS 358
- 8.9.5 BUSINESS STRATEGY 360
- 8.9.6 SWOT ANALYSIS 361
- 8.10 PENUMBRA, INC 362
- 8.10.1 OVERVIEW 362
- 8.10.2 FINANCIALS 363
- 8.10.3 PRODUCT PORTFOLIO 365
- 8.10.4 KEY DEVELOPMENTS 366
- 8.10.5 BUSINESS STRATEGY 367
- 8.10.6 SWOT ANALYSIS 368
- 8.11 PHENOX GMBH 369
- 8.11.1 OVERVIEW 369
- 8.11.2 FINANCIALS 369
- 8.11.3 PRODUCT PORTFOLIO 369
- 8.11.4 KEY DEVELOPMENTS 370
- 8.11.5 BUSINESS STRATEGY 371
- 8.11.6 SWOT ANALYSIS 372
- 8.12 STRYKER CORPORATION 373
- 8.12.1 OVERVIEW 373
- 8.12.2 FINANCIALS 374
- 8.12.3 PRODUCT PORTFOLIO 377
- 8.12.4 KEY DEVELOPMENTS 378
- 8.12.5 BUSINESS STRATEGY 380
- 8.12.6 SWOT ANALYSIS 381
- 8.13 TERUMO CORPORATION 382
- 8.13.1 OVERVIEW 382
- 8.13.2 FINANCIALS 383
- 8.13.3 PRODUCT PORTFOLIO 387
- 8.13.4 KEY DEVELOPMENTS 388
- 8.13.5 BUSINESS STRATEGY 390
Summary:
Get latest Market Research Reports on Neurovascular Intervention Devices. Industry analysis & Market Report on Neurovascular Intervention Devices is a syndicated market report, published as Neurovascular Intervention Devices Global Market - Forecast to 2024. It is complete Research Study and Industry Analysis of Neurovascular Intervention Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
